Full Coverage

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

                   
pr-inside.com
Nov 3, 2009
 
Story Timeline:  24 days

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational... [read full story]                    

powered by
Add Comment
Latest article on this story:

Ironwood And Forest Announce Positive Linaclotide Results From Two Pivotal Phase 3 Trials In...

 medicalnewstoday.com Nov 4, 2009
First article on this story:

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

 finanznachrichten.de Nov 3, 2009
Selected publications with coverage of this story:
xconomy.com scouty.de medicalnewstoday.com yahoo.com earthtimes.org finanzen.net drugs.com euroinvestor.co.uk pr-inside.com finanznachrichten.de
RELATED
Found 7 documents:
                   

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

drugs.com
Nov 3, 2009
 

Top-line Results Show Each Trial Met Primary and All Secondary Endpoints CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Nov 3, 2009 - Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced...

powered by

Ironwood, Forest Labs Drug for Chronic Constipation Passes Two Pivotal Trials

xconomy.com
Nov 3, 2009
 

Cambridge, MA-based Ironwood Pharmaceuticals has some new evidence out this morning that its lead drug candidate is an effective treatment for patients with chronic constipation. Ironwood and its partner, New York-based Forest...

powered by
                   

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in ...

scouty.de
Nov 3, 2009
 

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational...

powered by
                   
yahoo.com: Chart for FOREST LABS CL A yahoo.com

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

yahoo.com
Nov 3, 2009
 

CAMBRIDGE, Mass. & NEW YORK----Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of...

powered by
                   

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

finanzen.net
Nov 3, 2009
 

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational...

powered by
                   

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

earthtimes.org
Nov 3, 2009
 

CAMBRIDGE, Mass. & NEW YORK - Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily...

powered by
                   

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

finanznachrichten.de
Nov 3, 2009
 

Top-line Results Show Each Trial Met Primary and All Secondary Endpoints Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials...

powered by